Latest From Georgetown University
AstraZeneca takes second license of antisense candidate under 2012 pact with Ionis, this time for kidney disease. Aldeyra is working with J&J on novel immune-modulating drugs for systemic inflammatory conditions.
A review of biopharma start-up dealmaking and financing from April through June 2016, based on data from Strategic Transactions.
A National Institutes of Health-sponsored trial appears to dash hopes that CT or MR imaging can help select patients for acute stroke treatment with first-generation thrombus retrieval systems.
The emerging market for wireless and remote monitoring technologies comes at a time when providers are looking for new tools to not only keep patients out of the hospital, but also to prevent unnecessary readmissions. These goals, along with a growing list of enabling technologies in the pipeline, are helping drive health care toward an era of unprecedented connectivity – one in which physicians and other care givers are able to monitor and even treat patients whenever needed wherever they may be – a shift that many believe will profoundly change health care as we know it.